JAPAN TO TEST FOR CAN­CER US­ING URINE SAM­PLES

Philippine Daily Inquirer - - WORLD -

TOKYO— A Ja­panese firm is poised to carry out what it hailed as the world’s first ex­per­i­ment to test for can­cer us­ing urine sam­ples, which would greatly fa­cil­i­tate screen­ing for the deadly dis­ease.

En­gi­neer­ing and IT con­glom­er­ate Hi­tachi de­vel­oped the ba­sic tech­nol­ogy to de­tect breast or colon can­cer from urine sam­ples two years ago.

It will now be­gin test­ing the method us­ing some 250 urine sam­ples, to see if sam­ples at room tem­per­a­ture are suit­able for anal­y­sis, Hi­tachi spokesper­son Chi­haru Odaira told Agence France-Presse (AFP).

Can­cer test made easy

“If this method is put to prac­ti­cal use, it will be a lot eas­ier for peo­ple to get a can­cer test, as there will be no need to go to a med­i­cal or­ga­ni­za­tion for a blood test,” he said.

It is also in­tended to be used to de­tect pe­di­atric can­cers.

“That will be es­pe­cially ben­e­fi­cial in test­ing for small chil­dren” who are of­ten afraid of nee­dles, added Odaira.

Re­search pub­lished ear­lier this year demon­strated that a new blood test has shown prom­ise to­ward de­tect­ing eight dif­fer­ent kinds of tu­mors be­fore they spread else­where in the body.

‘Biomarker’

Usual di­ag­nos­tic meth­ods for breast can­cer con­sist of a mam­mo­gram fol­lowed by a biopsy if a risk is de­tected.

For colon can­cer, screen­ing is gen­er­ally con­ducted via a stool test and a colonoscopy for pa­tients at high risk.

The Hi­tachi tech­nol­ogy cen­ters around de­tect­ing waste ma­te­ri­als in­side urine sam­ples that act as a “biomarker,” a nat­u­rally oc­cur­ring sub­stance by which a par­tic­u­lar dis­ease can be iden­ti­fied, the com­pany said in a state­ment.—

Newspapers in English

Newspapers from Philippines

© PressReader. All rights reserved.